Complete FDA and NHTSA recall records dated in May 2014.
These records include useful source details for the selected month.
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.
Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.
Defective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Presence of Precipitate: Small amounts of diphenydramine and mannitol precipitated out of solution.
Failed Stability Specifications: Out of specification results for viscosity in one lot of Glytone Acne Treatment Facial Cleanser.
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Labeling: Incorrect Expiration Date; Expiration date is earlier than listed on vial.
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide
Marketed Without an Approved NDA/ANDA: FDA lab results found undeclared API Fluoxetine in this dietary supplement.
Failed Dissolution Specifications: Stability results found the product did not meet the drug release dissolution specifications.
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Failed Dissolution Specifications: Stability results found the product did not meet the drug release dissolution specifications.
Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide
Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles.
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.
